Quebec - Bausch Health Companies Inc. (NYSE/TSX: BHC) will release first-quarter 2024 financial results on Thursday, May 2, 2024.
Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
Conference Call Details
Date: Thursday, May. 02, 2024
Time: 8:00 a.m. U.S. EDT
Webcast: http://ir.bauschhealth.com/events-and-presentations
A replay of the conference call will be available on the investor relations website.
To participate in the live Q&A session, please register using this link to receive a PIN, which will be sent an hour before the conference call.
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health outcomes. We develop, manufacture and market a range of products, primarily in gastroenterology, hepatology, neurology, dermatology, medical aesthetic devices, international pharmaceuticals, and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.
Contact:
Garen Sarafian
Email: ir@bauschhealth.com
Tel: (877) 281-6642
Kevin Wiggins
Email: corporate.communications@bauschhealth.com
Tel: (908) 541-3785
(C) 2024 Electronic News Publishing, source ENP Newswire